Drug-labels.com

SPC-Ropinirole: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
0.25 mg, 0.5 mg, 1 mg, 2 mg, 5 mg
ATC code:

Patient Medication Information: uses, side effects, how to take - SPC-Ropinirole

ABOUT THIS MEDICATION

What the medication is used for:

SPC-ROPINIROLE, also known as ropinirole, is used to treat the signs and symptoms of Parkinson's disease.

You may receive SPC-ROPINIROLE on its own, but it may also be given with another drug used to treat Parkinson's disease.

What it does:

SPC-ROPINIROLE belongs to the family of medicines called dopamine agonists. SPC-ROPINIROLE improves some of the chemical imbalance in the part of the brain affected by Parkinson’s disease.

When it should not be used:

Do not use SPC-ROPINIROLE if you are allergic to it or any of the components of its formulation (see list below). SPC-ROPINIROLE is not recommended for children under 18 years of age.

What the medicinal ingredient is:

ropinirole hydrochloride

What the nonmedicinal ingredients are:

Non-medicinal ingredients include: croscarmellose sodium, FD & C Blue #2 (1.0 mg and 5.0 mg tablets), hypromellose, iron oxide black (1.0 mg), iron oxide red (2.0 mg), iron oxide yellow (0.5 mg and 1.0 mg tablets), lactose anhydrous, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, polyethylene glycol 4000 (5.0 mg), talc (0.25 mg and 5.0 mg tablets), titanium dioxide.

What dosage forms it comes in:

SPC-ROPINIROLE is available as 0.25 mg, 0.5 mg, 1.0 mg, 2.0 mg and 5.0 mg tablets.

WARNINGS AND PRECAUTIONS

You are warned of a sudden onset of sleep condition which may occur without warning, while taking SPC-ROPINIROLE. You should not operate machinery or engage in activities that require alertness, as you may put yourself and others at risk of serious injury or death. This sudden onset of sleep condition has also been reported in patients taking other similar anti-Parkinson drugs.

What should I know before taking SPC-ROPINIROLE:

Studies of people with Parkinson’s disease show that they may be at an increased risk of developing melanoma, a form of skin cancer, when compared to people without Parkinson’s disease. It is not known if this problem is associated with Parkinson’s disease or the drugs used to treat Parkinson’s disease. SPC-ROPINIROLE is one of the drugs used to treat Parkinson’s disease, therefore, patients treated with SPC-ROPINIROLE should have periodic skin examinations.

Drop in Blood Pressure

While taking SPC-ROPINIROLE, you may experience a drop in blood pressure that may make you feel dizzy or faint especially when standing up from a sitting or lying position.

Neurological Disorder

Symptoms resembling a neurological disorder (Neuroleptic Malignant Syndrome) characterized by fever, muscle stiffness, stupor and unstable involuntary actions have been reported in relation to changes in treatment, reduction of treatment dose and stopping treatment.

SPC-ROPINIROLE taken with L-dopa

SPC-ROPINIROLE may amplify the side effects of L-dopa (also called levodopa) and may cause or worsen pre-existing uncontrolled jerky movements (dyskinesia). Tell your doctor if this happens as the dose of your medicines may need adjusting.

Eye Disorders

If you have albinism (lack of pigmentation in skin or hair), you may have an increased risk of eye disorders while taking SPC-ROPINIROLE compared to people without albinism. Therefore, you should take SPC-ROPINIROLE only under an ophthalmologist’s (doctor who specializes in eye disorders) care.

Hallucinations

While taking SPC-ROPINIROLE, you may experience hallucinations, such as seeing or hearing things that aren’t really there.

Psychiatric Disorders

Impulse control symptoms including compulsive behaviours, e.g. feeling an urge to gamble, hypersexuality, compulsive shopping, or binge eating, as well as aggression have been reported with the use of ropinirole tablets.

BEFORE you use SPC-ROPINIROLE talk to your doctor or pharmacist if you:

  • have any health problem, especially any heart, liver or kidney condition.
  • have previously taken SPC-ROPINIROLE and became unwell.
  • have any allergies or reactions to foods or drugs.
  • are pregnant or think you may be pregnant, or if you are breast feeding. You should not be taking SPC-ROPINIROLE if you are pregnant or breast feeding.

  • are taking any other medications, including any drugs you can buy without a prescription.
  • have experienced any unusual urges and/or behaviours (such as excessive gambling or excessive sexual behaviour). (See SIDE EFFECTS AND WHAT TO DO ABOUT THEM)

INTERACTIONS WITH THIS MEDICATION

Other medications may be affected by SPC-ROPINIROLE or may affect how SPC-ROPINIROLE works. Do not take any other medication, including any drugs or herbal products you can buy without a prescription. Tell any other doctor, dentist or pharmacist that you talk to that you are taking SPC-ROPINIROLE.

Drug-drug Interaction:

Drugs that may interact with SPC-ROPINIROLE include:

  • a drug used to help with breathing difficulties

    called theophylline

  • an antibiotic called ciprofloxacin
  • any hormone replacement therapy (HRT)EASE A
  • other dopamine agonists, e.g. L-dopa: SPC-ROPINIROLE may make some of the side effects of L-dopa worse, e.g. jerky movement.
  • certain medicines called neuroleptics used to treat

    schizophrenia and other serious mental illnesses

  • digoxin, a heart medicine that is used to treat

    congestive heart failure or certain heartbeat irregularities

Drug-lifestyle Interaction:

  • SPC-ROPINIROLE may affect your ability to remain alert while doing normal daily activities. You should refrain yourself from doing activities such as driving a car, doing physical tasks or

    • using hazardous machinery until you know how SPC-ROPINIROLE affects you.
    • Because SPC-ROPINIROLE can make you feel sleepy, tell your doctor or pharmacist if you are planning to drink alcohol.

Before making any change to other medications you are taking, or stopping them, talk to your doctor first.

PROPER USE OF THIS MEDICATION

Usual dose:

Follow the doctor's instructions about how and when you should take your tablets. Your doctor will decide how many tablets you need to take each day and you should always follow his/her instructions. When you first start taking SPC-ROPINIROLE, the amount you take will be increased gradually.

Your doctor may adjust the amount that you are taking. You will usually be told to take SPC-ROPINIROLE three times a day. You should not change the dose or discontinue treatment with SPC-ROPINIROLE without the recommendation of your doctor.

If you are taking other medicines for Parkinson's disease, the doctor may adjust the dose of these medicines while you are taking SPC-ROPINIROLE.

You should swallow the tablets whole with water. Do not chew. SPC-ROPINIROLE can be taken with or without food.

You should continue to take your medicine even if you do not feel better, as it may take a number of weeks for the medicine to work.

REMEMBER: THIS MEDICINE IS FOR THE PERSON NAMED BY THE DOCTOR. DO NOT GIVE IT TO ANYBODY ELSE.

Overdose:

If you think you, or a person you are caring for, have taken too much SPC-ROPINIROLE, contact a healthcare professional, hospital emergency department, regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

If you or someone you know have taken too many tablets all at once, you should get medical help immediately, either by calling your doctor, the Regional Poison Control Centre, or the nearest hospital (do not drive yourself). Always take the labelled medicine container with you even if there are no tablets left.

Missed Dose:

If you have forgotten to take SPC-ROPINIROLE, do not take extra doses to make up for forgotten individual doses. When you do remember to take SPC-ROPINIROLE, take your next dose of SPC-ROPINIROLE at the usual time. If you have missed taking SPC-ROPINIROLE for one day or more consult your doctor for advice on restarting SPC-ROPINIROLE.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medications, SPC-ROPINIROLE tablets can cause some side effects. You may not experience any of them. For most patients these side effects are likely to be minor and temporary. However, some may be serious. Consult your doctor if you experience these or other side effects.

Some of the most commonly reported side effects of SPC-ROPINIROLE tablets are:

  • Feeling or being sick
  • Stomach ache
  • Dizziness or light-headedness, fainting
  • Sleepiness
  • Headache
  • Some leg swelling
  • Tiredness
  • Viral infection
  • Feeling full and bloated or experiencing heartburn
Serious side effects and what to do about them
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Very common

Uncontrollable

movements

(dyskinesias)

✓
CommonHallucinations, feeling confused✓
Uncommon

Having severe confusion, irrational ideas or feeling

irrational suspiciousness,

other psychotic reactions, impulse control (symptoms like increased libido, feeling the urge to gamble, to shop or eat, acting in an

aggressive manner)

✓
Very rare

Allergic

reactions (symptoms like red, itchy swellings on the skin, swelling of the face, lips, mouth, tongue

or throat, difficulty

swallowing or breathing, rash or intense itching)

✓

Extreme

sleepiness, falling asleep without warning

✓

This is not a complete list of side effects. For any unexpected effects while taking SPC-ROPINIROLE, contact your doctor or pharmacist.

HOW TO STORE IT

The expiry date of this medicine is printed on the label. Do not use the medicine after this date.

Bottles: Keep your tablets in their original pack in a dry place away from light and moisture. They should be stored between 15 and 30° C. Close container tightly after each use.

Cartons: Keep your tablets in their original pack in a dry place away from light and moisture. They should be stored between 15 and 30° C.

Keep out of reach and sight of children.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about SPC-ROPINIROLE:

•

  • Talk to your healthcare professional

•

  • Find the full product monograph that is prepared for

    healthcare professionals and includes this Consumer

    Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); or by calling

    1-866-840-1340.

Sun Pharma Canada Inc.

Brampton, ON L6T 1C1

Last revised: JUN 26, 2025

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02314037

Revision date stated in the text: June 26, 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for SPC-Ropinirole

Rx or OTC
Prescription (Rx)?
DIN 02314037, 02314045, 02314053, 02314061, 02314088
Schedule(s) PRESCRIPTION
Active ingredient(s) Ropinirole (ropinirole hydrochloride)
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N04 Anti-parkinson drugs
      1. N04B Dopaminergic agents
        1. N04BC Dopamine agonists
          1. N04BC04 Ropinirole
Company SUN PHARMA CANADA INC
Strengths and forms
DIN Strength Dosage form(s) Current status
02314037 0.25 MG Tablet Marketed June 26, 2025
02314045 0.5 MG Tablet Approved June 26, 2025
02314053 1 MG Tablet Marketed June 26, 2025
02314061 2 MG Tablet Marketed June 26, 2025
02314088 5 MG Tablet Marketed June 26, 2025

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.